Evolocumab & Inclisiran dual therapy for further LDL lowering in a very high cardiovascular risk Familial Hypercholesterolaemia patient with heterozygous gain of function PCSK9 mutation

• R. Gingell,
• P. Das,
• Y.P. Teoh

Affiliations

R. Gingell

All Wales Familial Hypercholesterolaemia Service (North Wales), Glan Clwyd Hospital, Denbighshire, UK

P. Das

Department of Cardiology, Glan Clwyd Hospital, Denbighshire, UK

Y.P. Teoh

Department of Chemical Pathology & Metabolic Medicine, Wrexham Maelor Hospital, Wrexham, UK